Litcius/Paper detail

Comparative effectiveness of combination therapy with nirmatrelvir–ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir–ritonavir in patients hospitalised with COVID-19: a target trial emulation study

Ming Hong Choi, Eric Yuk Fai Wan, Ian Chi Kei Wong, Esther W. Chan, Wing Ming Chu, Anthony Raymond Tam, Kwok Yung Yuen, Ivan Fan Ngai Hung

2024The Lancet Infectious Diseases37 citationsDOIOpen Access PDF

Topics & Concepts

RitonavirCoronavirus disease 2019 (COVID-19)MedicineEmulationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyLopinavir/ritonavirPharmacologyHuman immunodeficiency virus (HIV)Viral loadAntiretroviral therapyInternal medicinePsychologyDiseaseSocial psychologyOutbreakInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesPharmacological Receptor Mechanisms and Effects
Comparative effectiveness of combination therapy with nirmatrelvir–ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir–ritonavir in patients hospitalised with COVID-19: a target trial emulation study | Litcius